GABA(B) receptors: Drugs meet clones

Current Opinion in Neurobiology

Volumn 8, Issue 3, 1998, Pages 345-350

  Bettler, Bernhard ^a   Kaupmann, Klemens ^a   Bowery, Norman ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; NEUROTRANSMITTER RECEPTOR; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BACLOFEN;

BRAIN; MOLECULAR CLONING; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; BRAIN LEVEL; CHEMISTRY; DRUG POTENTIATION; GENETICS; HUMAN; PHYSIOLOGY; SIGNAL TRANSDUCTION;

BACLOFEN; BRAIN CHEMISTRY; CLONING, MOLECULAR; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; RECEPTORS, GABA-B; SIGNAL TRANSDUCTION;

EID: 0032081247     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(98)80059-7     Document Type: Article

References (35)

1. B sites in rat brain. Nature. 290:1981;149-152.
2. Wu LG, Saggau P. Presynaptic inhibition of elicited neurotransmitter release. of special interest Trends Neurosci. 20:1997;204-212 A comprehensive review of the different mechanisms that control neurotransmitter release.
3. Curtis DR, Gynther BD, Lacey G, Beattie DT. Baclofen: reduction of presynaptic calcium influx in the cat spinal cord in vivo. Exp Brain Res. 113:1997;520-533.
4. Thompson SM, Capogna M, Scanziani M. Presynaptic inhibition in the hippocampus. Trends Neurosci. 16:1993;222-227.
5. B receptors associated with cAMP production in rat brain. Brain Res. 720:1996;220-224.
6. B receptors in the hippocampus have different pharmacological properties. Neuron. 1:1988;585-591.
7. B receptors within the rat dorsolateral septal nucleus. J Pharmacol Exp Ther. 280:1997;129-137.
8. + conductance, while the CACA-sensitive ones do not. This report supports previous findings on a CACA-sensitive metabotropic GABA receptor in goldfish retinal bipolar cells.
9. B receptors in human brain: phaclofen- and CGP52432-sensitive, CGP35348-insensitive autoreceptors and phaclofen and CGP52432-insensitive, CGP35348-sensitive heteroreceptors. The data confirm previous findings of the same laboratory obtained with rat receptors. These reports clearly argue for receptor subtypes, as the rank order of antagonist efficacy at auto- and heteroreceptors is different; however, the claim of presynaptic receptor subtypes has been challenged by Waldmeier et al. [17].
10. B receptor effects contribute to PPD: a short-lasting effect, sensitive to CGP35348, and a long-lasting effect, insensitive to CGP35348.
11. B binding sites in the brain.
12. B receptors.
13. Sack JS, Saper MA, Quiocho FA. Periplasmic binding protein structure and function. Refined X-ray structure of the leucine/isoleucine/valine-binding protein and its complex with leucine. J Mol Biol. 206:1989;171-191.
14. Harrison NL. On the presynaptic action of baclofen at inhibitory synapses between cultured rat hippocampal neurones. J Physiol (Lond). 422:1990;433-446.
15. Pin JP, Bockaert J. Get receptive to metabotropic glutamate receptors. Curr Opin Neurobiol. 5:1995;342-349.
16. Kenakin T. Differences between natural and recombinant G-protein coupled receptor systems with varying receptor/G-protein stoichiometry. of outstanding interest Trends Pharmacol Sci. 18:1997;456-464 This article illustrates, on a theoretical scale, how, for G-protein-coupled receptors, differences between recombinant and natural expression systems may lead to anomalies in drug testing. The various effects are discussed in the context of ligand binding and functional receptor studies.
17. B receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors. Br J Pharmacol. 113:1994;1515-1521.
18. B receptors present on primary afferent terminals of the spinal cord? Nature. 307:1984;71-74.
19. BR1 receptors are also found postsynaptically at synapses made between amacrine and ganglion cells or between amacrine cells. These data show that the cloned receptors can segregate to both pre- and postsynaptic sites.
20. O'Callaghan JFX, Jarolimek W, Lewen A, Misgeld U. Baclofen-induced and constitutively active inwardly rectifying potassium conductases in cultured rat midbrain neurons. Pflügers Arch. 433:1996;49-57.
21. B receptors-activated inwardly rectifying potassium current in dissociated hippocampal CA3 neurons. J Neurosci. 16:1996;6374-6385.
22. + channels that differ from the Kir3.0 channels.
23. 2+ entry and/or the secretion process itself. The authors suggest that the same receptor can couple to different effector systems according to its subcellular localization in the neuron.
24. B receptors couple to Kir3.1+Kir3.2 heteromultimers.
25. B R1 receptor mutations could be causal in the inherited predisposition to juvenile myoclonic epilepsy and possibly other forms of epilepsy.
26. Ikeda SR. Voltage-dependent modulation of N-type calcium channels by G-protein beta gamma subunits. Nature. 380:1996;255-258.
27. B receptor-mediated events to inflammatory pain processing: carrageenan oedema and associated spinal c-Fos expression in the rat. Neuroscience. 73:1996;487-496.
28. Malcangio M, Bowery NG. GABA and its receptors in the spinal cord. Trends Pharmacol Sci. 17:1996;457-462.
29. B receptor antagonists: potential new anti-absence drugs. J Neural Transm. 35:1992;179-188. of outstanding interest.
30. Kim U, Sanchez-Vives MV, McCormick DA. Functional dynamics of GABAergic inhibition in the thalamus. of outstanding interest Science. 278:1997;130-134 It is shown how different functional properties of GABAergic inhibition can reconfigure the operations of thalamocortical networks into patterns of activity associated with waking, slow-wave sleep, and generalized seizures.
31. Roberts DC, Andrews MM. Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure. of special interest Psychopharmacology. 131:1997;271-277 This report shows that acute treatment with baclofen suppresses cocaine self-administration in rats. The authors suggest using baclofen as pharmacotherapeutic agent to suppress cocaine craving during the early phase of cocaine withdrawal.
32. Chou KC, Heinrikson RL. Prediction of the tertiary structure of the complement control module. J Protein Chem. 16:1997;765-773.
33. Kornau HC, Seeburg PH, Kennedy MB. Interaction of ion channels and receptors with PDZ domain proteins. of outstanding interest Curr Opin Neurobiol. 7:1997;368-373 A thorough review on the functional implications of PDZ domain interactions.
34. B receptors.
35. Thompson SM, Gahwiler BH. Comparison of the actions of baclofen at pre- and postsynaptic receptors in the rat hippocampus in vitro. J Physiol (Lond). 451:1992;329-345.